EndocrinologyTier 2Disease (DEADMAN)

Secondary hypertensive disorders - phaeochromocytoma

Description

  • Catecholamine-secreting tumour of chromaffin cells
    • Phaeochromocytoma = adrenal medulla (~80-90%)
    • Paraganglioma = extra-adrenal sympathetic (abdominal, organ of Zuckerkandl) or parasympathetic (head and neck - usually non-secretory)
  • *All are potentially malignant - there is no benign histology. "Malignant" is defined only by metastasis to a site where chromaffin tissue does not normally occur*
The rule of tens - outdated but examined
  • 10% extra-adrenal, 10% bilateral, 10% malignant, 10% familial
  • *Now: ~40% are germline, ~15-20% metastasise, ~15-20% extra-adrenal* - the genetics figure is the one that has changed most
Secretory phenotype predicts the syndrome
PhenotypeGenesClinical
Adrenergic (adrenaline + noradrenaline)RET, NF1, sporadic adrenalParoxysmal, palpitations, anxiety, hyperglycaemia
NoradrenergicVHL, SDHxSustained hypertension, fewer spells
DopaminergicSDHB, SDHDNormotensive or hypotensive, nausea; often missed
Presentation
  • Headache ~90%, hypertension (sustained or paroxysmal) 85-95%, sweating 60-70%
    • Triad of headache + palpitations + diaphoresis: sensitivity ~89%, specificity ~67%
  • Paroxysms lasting minutes: pallor (not flushing), tremor, anxiety/impending doom, chest or abdominal pain
  • Orthostatic hypotension in an untreated hypertensive is a classic clue (chronic volume contraction + desensitised receptors)
  • Weight loss, hyperglycaemia, constipation
  • Catecholamine cardiomyopathy, arrhythmia, pulmonary oedema
  • ~10-15% are found incidentally and are entirely asymptomatic

6 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.

Get premium access